home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410b.zip
/
M94A0299.TXT
< prev
next >
Wrap
Text File
|
1994-10-08
|
3KB
|
48 lines
Document 0299
DOCN M94A0299
TI Squamous-cell carcinoma of the anus in HIV-positive patients.
DT 9412
AU Chadha M; Rosenblatt EA; Malamud S; Pisch J; Berson A; Department of
Radiation Oncology, Beth Israel Medical Center, New; York, New York
10003.
SO Dis Colon Rectum. 1994 Sep;37(9):861-5. Unique Identifier : AIDSLINE
MED/94357034
AB PURPOSE: Patients diagnosed as having anal cancer and human
immunodeficiency virus (HIV)-positive disease were evaluated for
response to treatment and its associated toxicity. METHODS: We studied
nine HIV-positive patients with squamous-cell carcinoma of the anus.
Among them, three patients had acquired immunodeficiency syndrome
(AIDS). The stage of disease at presentation included: one Stage 0, two
Stage I, two Stage II, and four Stage III patients. Seven patients
received combined modality treatment, i.e., radiation therapy and
chemotherapy, and two patients received radiation therapy alone. The
radiation therapy field included the pelvis and a conedown boost.
Chemotherapy consisted of two cycles of 5-fluorouracil and mitomycin C.
Patients have been followed from 2 to 42 (median, 8) months. RESULTS:
Seven patients achieved a complete response clinically. All Stage I/II
patients and one of four Stage III patients remain alive and have no
evidence of disease. Radiation Therapy Oncology Group/European
Organization for the Research and Treatment of Cancer Grades 3 and 4
skin toxicity were noted in six patients, and Grades 2 and 3
myelosuppression were noted in eight patients. The response rates
achieved are comparable to the experience in non-HIV patients reported
in the literature, but toxicity seems to be increased. CONCLUSION: It
would seem reasonable to offer combined modality treatment to early
stage, HIV-positive patients with good performance status and a history
of minor opportunistic infections. The value of combined modality in
AIDS patients and those who present with advanced stages of the disease
is questionable.
DE Acquired Immunodeficiency Syndrome/*COMPLICATIONS Adult Aged
Antineoplastic Agents, Combined/*THERAPEUTIC USE Anus
Neoplasms/DIAGNOSIS/ETIOLOGY/MORTALITY/*RADIOTHERAPY Carcinoma,
Squamous Cell/DIAGNOSIS/ETIOLOGY/MORTALITY/ *RADIOTHERAPY Combined
Modality Therapy Female Fluorouracil/ADMINISTRATION & DOSAGE
Follow-Up Studies Human HIV Seropositivity/*COMPLICATIONS Male
Middle Age Mitomycin C/ADMINISTRATION & DOSAGE Neoplasm Staging
Retrospective Studies Risk Factors Survival Rate Treatment Outcome
JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).